IONS
NASDAQ · Biotechnology
Ionis Pharmaceuticals Inc
$44.90
+0.46 (+1.04%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
-26.83%
YTD
-43.64%
Open$44.95
Previous Close$44.44
Day High$45.25
Day Low$44.20
52W High$86.74
52W Low$44.66
Volume—
Avg Volume4.93M
Market Cap7.45B
P/E Ratio—
EPS$-3.47
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$80.92
Below
SMA 200
$60.03
Below
RSI (14)
47.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
32 analysts
Price Target
+66.9% upside
Current
$44.90
$44.90
Target
$74.94
$74.94
$58.43
$74.94 avg
$113.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 988.94M | 844.39M | 6.52B |
| Net Income | -399,665,591 | -307,120,075 | -1,853,302,223 |
| Profit Margin | -40.4% | -38.4% | -28.4% |
| EBITDA | -389,487,407 | -315,926,431 | -2,518,216,651 |
| Free Cash Flow | — | — | -1,126,512,375 |
| Rev Growth | +17.1% | +17.1% | -9.9% |
| Debt/Equity | 4.77 | 4.77 | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |